Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Expression of Concern]
Hinz M, Stein A, Uncini T. Int J Nephrol Renovasc Dis. 2011;4:101–113. The Editor-in-Chief and Publisher of International Journal of Nephrology and Renovascular Disease wish to issue an Expression of Concern for the published article. Concerns have been raised re...
Main Authors: | Hinz M, Stein A, Uncini T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | International Journal of Nephrology and Renovascular Disease |
Subjects: | |
Online Access: | https://www.dovepress.com/eoc-validity-of-urinary-monoamine-assay-sales-under-the-ldquospot-base-peer-reviewed-article-IJNRD |
Similar Items
-
Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01) -
Relative Nutritional Deficiencies Associated with Centrally Acting Monoamines [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01) -
Quantitative determination of monoamine neurotransmitters in rat brain homogenates using HPLC-MS/MS
by: N. S. Popov, et al.
Published: (2023-01-01) -
Monoaminergic Modulation of Learning and Cognitive Function in the Prefrontal Cortex
by: Natalie Boyle, et al.
Published: (2024-09-01) -
Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
by: Ole Valente Mortensen, et al.
Published: (2015-09-01)